Abbarin N, Papp K, Vender R, Langley R, Ho V, Park-Wyllie L, Miller M, You Y, Yang Y-W. PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s237. Available from: https://jofskin.org/33014/index.php/skin/article/view/2457